首页|髓母细胞瘤肿瘤微环境及免疫治疗新策略研究进展

髓母细胞瘤肿瘤微环境及免疫治疗新策略研究进展

扫码查看
髓母细胞瘤(medulloblastoma,MB)是儿童最常见的恶性脑肿瘤,5年总生存率(overall survival,OS)约70%.近年来,肿瘤微环境在肿瘤生长中的作用引起广泛关注.研究显示,肿瘤相关巨噬细胞(tumor-associated macrophage,TAM)、T细胞、NK细胞、B细胞等免疫细胞以及肿瘤相关星形细胞(tumor-associated astrocyte,TAA)与肿瘤细胞的相互作用在MB发生和发展过程中可能发挥重要作用.了解MB的肿瘤免疫微环境,探讨肿瘤细胞和免疫细胞之间的相互作用关系,对于改进肿瘤的免疫治疗策略至关重要.该文将对MB的肿瘤微环境及免疫治疗策略的研究进展展开综述.
Research advances on the tumor microenvironment and new immunotherapy strategies for medulloblastoma
Medulloblastoma(MB)is the most common pediatric brain malignancy,with a 5-year overall survival(OS)rate of around 70%.In recent years,the role of the tumor microenvironment on tumor growth has attracted extensive attention.The interaction between tumor cells and other cells in the tumor microenvironment including tumor-associated macrophages(TAM),T cells,NK cells,B cells,and tumor-associated astrocytes(TAA)plays an important role in the onset and progres-sion of MB.Understanding the tumor immune microenvironment of this tumor,especially the relationship between tumor and immune cells,is crucial for the effective development of immune-based therapeutic strategies for MB.This review summarizes the latest research progress on the tumor microenvironment and immunotherapy of MB.

medulloblastomatumor immune microenvironmentimmunotherapy

柴晓东、李海爽、裴斐、常青

展开 >

北京大学医学部基础医学院 病理学系,北京 100191

北京大学第三医院 病理科,北京 100191

北京市神经外科研究所,北京 100070

髓母细胞瘤 肿瘤免疫微环境 免疫治疗

国家自然科学基金国家自然科学基金

8197235381101900

2024

现代免疫学
上海市免疫学研究所,上海市免疫学会

现代免疫学

CSTPCD
影响因子:0.4
ISSN:1001-2478
年,卷(期):2024.44(5)